General information
All the reactions were monitored by TLC analysis.
1 H and 13 C NMR spectra were recorded without any internal standard. 1 H NMR spectra & 13 C NMR spectra were recorded on 400 MHz and 101 MHz (Bruker) AVANCE II/AVANCE III instruments respectively. Chemical shifts are reported in ppm and calibrated for CDCl 3 (δ = 7.27 ppm) for 1 H NMR and (δ = 77.0 ppm) for 13 C NMR spectroscopy. Coupling constants were measured in Hz. High Resolution Mass
Spectroscopy data of the products were acquired using Agilent 6520 Q-TOF instruments with
Mass hunter software. Column chromatographic purifications were performed on a CombiFlash
Rf (Teledyne Isco) with silica gel (230-400 mesh particle size) using cyclohexane and ethylacetate as the mobile phase. Melting points were determined with a SRS-OptiMelt digital melting point apparatus and are uncorrected. DFT calculations were carried out with B3LYP/6-31G** level of theory with full geometry optimization. Gas phase energies for the four molecules (Scheme 3)
were calculated using the Jaguar software, available in Schrodinger's Maestro modelling suite (version 9.9.013).
Optimization of reaction conditions with transition metal reagents:
Reductant, solvent 1a 3a 2a
Scheme 1: The optimisation of conversion of 1a to 3a using various reducing agents. 
Details of DFT study:
Theoretical calculations were carried out with DFT calculations (B3LYP/6-31G** level of theory) with full geometry optimization ( Figure 2 ) of 2a as well as 2n (a molecule with p-amino group).
Assuming, that the first step in the reductive cleavage is addition of an electron to the ∆ 2 -isoxazoline ring to form a radical anion, the difference in the energy changes (∆∆E, equation 1) for the two processes (2a 1 ∆2a 1-· versus 2n∆2n -· ) reflects the extent to which the ortho-amino group stabilizes (or destabilizes) the radical anion. Gas phase energies for the four molecules (Scheme 3) were calculated using the Jaguar software, available in Schrodinger's Maestro modelling suite (version 9.9.013). These energies as shown in Scheme 3 were used to calculate the stability of the radical anions, with respect to their neutral counterparts.
The gas phase energy in Scheme 3 indicates that the ortho-amino group stabilized the formation of the radical anion by ∆∆E of -0.006567 Ha (or -17.2 kJ/mol,) compared to the non-hydrogen bonded form. The extent to which this stabilization might speed up the reductive cleavage reaction can be estimated using the Arrhenius equation (equation 2), assuming that the radical anion is the transition state for the reaction. It can be speculated from the above calculations that the ortho-amino-group stabilizes the radical anion and lowers the activation energy (Ea) by 17.2 kJ/mol. From the Arrhenius equation, this equates to an acceleration in the rate of reaction by 1000-fold, which is consistent with the experimental observation, that the ortho-amino group is required for the reductive cleavage of the ∆ 2 -isoxazoline ring. and water (7.0 ml). The resulting suspension was stirred at 80 o C for 6h and monitored by TLC and LC-MS. The reaction mixture was allowed to cool to 25 o C, and filtered through a bed of celite. The filtrate was distilled under reduced pressure and the resulting aqueous phase was extracted with ethyl acetate (3 × 5.0 ml). The combined organic layer was washed with water (5.0 ml) followed by brine (5.0 ml each), dried over sodium sulfate (anhyd.), filtered and concentrated under reduced pressure. The crude residue was purified by flash chromatography using silica gel with ethyl acetate and cyclohexane as the mobile phase to yield the desired product 3a-m.
Method 2:
To a solution of 2'-nitroaryl-Δ 2 -isoxazoline 1 (1.00 mmol. 1.0 equiv.) in DMSO (7.0 ml) was added sodium dithionite (6.00 mmol, 6.0 equiv.) at 25 o C. The suspension was warmed to 100 o C and stirred for 3-5 h. The reaction was monitored by TLC and LC-MS and after complete conversion the reaction mixture was cooled to 25 o C. The reaction mass was poured into an ice cold solution of sodium hydroxide and stirred for 10 min. The aqueous phase was extracted with diethyl ether (3 x 10.0 ml) and the combined organic layer was washed with water (10.0 ml) followed by brine solution (10.0 ml each), dried over sodium sulfate (anhyd.), filtered and the filtrate was concentrated under reduced pressure to isolate the crude product. The product was purified by flash chromatography using silica gel with ethyl acetate and cyclohexane as the mobile phase.
2-phenylquinoline (3a):
The product 3a was isolated using method 
2-(4-bromophenyl)quinoline (3b):
The product 3b was isolated using 
2-(4-methoxyphenyl)quinoline (3d):
The product 3d was isolated using 
2-(2-thienyl)quinoline (3e):
The product 3e was isolated using 
2-(6-bromo-2-pyridyl)quinoline (3f):
The product 3f was isolated using 
2-(2-quinolyl)aniline (3g):
The product 3g was isolated using 
tert-butyl 2-methyl-4-(2-quinolyl)benzoate (3h):
The product 3h was isolated using 
3-chloro-4-(2-quinolyl)aniline (3i):
The product 3i was isolated using method 1: 188 mg, Yield 74%,off white gum. 1 H NMR (CDCl 3 , 400MHz): 254.0611.
2-(3-pyridyl)quinoline (3j):
The product 3j was isolated using method 1: 148 mg, Yield 72%, and method 2: 134 mg, Yield 65%, white 
2-(2-bromo-4-chloro-phenyl)quinoline (3k)
The product 3k was isolated using 
2-(2-fluorophenyl)quinoline (3m)
The product 3m was isolated using method 1: 180 mg, Yield 81%, and 
5-(2-nitrophenyl)-3-phenyl-4,5-dihydroisoxazole (1a):
The product 1a (217 mg) was isolated using general procedure, Yield 81%, white solid, MP= 119-120 o C. 345.9919.
3-(4-chloro-2-fluoro-phenyl)-5-(2-nitrophenyl)-4,5-dihydroisoxazole (1c):
The product 1c (268 mg) was isolated using general procedure, Yield 84%, off white solid, MP=125-127 
3-(4-methoxyphenyl)-5-(2-nitrophenyl)-4,5-dihydroisoxazole (1d):
The product 1d (234 mg) was isolated using general procedure, Yield 79%, off white solid, MP=120 
3-(6-bromo-2-pyridyl)-5-(2-nitrophenyl)-4,5-dihydroisoxazole (1f):
The product 1f (314 mg) was isolated using general procedure, Yield 90%, off white solid, MP=120-122 
3,5-bis(2-nitrophenyl)-4,5-dihydroisoxazole (1g):
The product 1g (241 mg) was isolated using general procedure, Yield 77%, off white solid, MP=120-121 
tert-butyl 2-methyl-4-[5-(2-nitrophenyl)-4,5-dihydroisoxazol-3-yl]benzoate (1h):
The product 1h (313 mg) was isolated using general procedure, Yield 82%,white solid, MP=167-168 o C. 
3-(2-chloro-4-nitro-phenyl)-5-(2-nitrophenyl)-4,5-dihydroisoxazole (1i):
The product 1i (294 mg) was isolated using general procedure, Yield 85%, off white solid, MP=108-109 
5-(2-nitrophenyl)-3-(3-pyridyl)-4,5-dihydroisoxazole(1j):
The product 1j (188 mg) was isolated using general procedure, Yield 70%, off white solid, MP=115-116 
3-(2-bromo-4-chloro-phenyl)-5-(2-nitrophenyl)-4,5-dihydroisoxazole(1k):
The product 1k (310 mg) was isolated using general procedure, Yield 82%, MP=85-86 
5-(2-nitrophenyl)-3-(2,4,6-trifluorophenyl)-4,5-dihydroisoxazole(1l):
The product 1l (288 mg) was isolated using general procedure, Yield 90%, MP=75 322.0555.
3-(2-fluorophenyl)-5-(2-nitrophenyl)-4,5-dihydroisoxazole(1m):
The product 1m (254 mg) was isolated using general procedure, Yield 89%, MP=136-137 
